Trials / Conditions / Progressive Pulmonary Fibrosis

Progressive Pulmonary Fibrosis

14 registered clinical trials studyying Progressive Pulmonary Fibrosis — 11 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Evaluating the Efficacy and Safety of of HSK44459 in People With Progressive Pulmonary Fibrosis NCT07503587	Haisco Pharmaceutical Group Co., Ltd.	Phase 3
Recruiting	Optimizing the Follow-Up Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-2 Trial NCT07486206	Hospital de Granollers	N/A
Recruiting	Study on the Efficacy of Quercetin Intake in Patients With Fibrotic Interstitial Lung Diseases. NCT07466420	Katerina M. Antoniou	N/A
Recruiting	SUPPORT-T in Patients With Progressive Pulmonary Fibrosis and Their Caregivers NCT07269262	Medical University of South Carolina	N/A
Recruiting	A Pilot Study to Assess Body Mass Composition Measurement Using BIA and Muscle Ultrasound in IPF and PPF Patie NCT07332117	Royal Brompton & Harefield NHS Foundation Trust	—
Recruiting	PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis NCT06855329	University of Massachusetts, Worcester	—
Recruiting	An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL) NCT06951217	Avalyn Pharma Inc.	Phase 2
Terminated	A Study to Test Whether BI 1839100 Improves Cough in People With Idiopathic Pulmonary Fibrosis or Progressive NCT06360094	Boehringer Ingelheim	Phase 2
Recruiting	A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Pa NCT06238622	Boehringer Ingelheim	Phase 3
Recruiting	A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis NCT06329401	Avalyn Pharma Inc.	Phase 2
Recruiting	Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETO NCT05943535	United Therapeutics	Phase 3
Active Not Recruiting	A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulm NCT06025578	Bristol-Myers Squibb	Phase 3
Enrolling By Invitation	Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease NCT04905693	United Therapeutics	Phase 3
Active Not Recruiting	Xenon MRI and Progressive ILD NCT05241275	Duke University	Phase 2